阿摩線上測驗
登入
阿摩線上測驗
登入
試卷名稱：111年 - 111 消化系內科專科醫師甄審試題#131307
年份：111年
科目：消化系內科專科醫師
79. 關於 Cholangiocarconoma(CCA)的敘述，下列何者正確？
(1) Adjuvant chemotherapy with capecitabine for 6 months after surgical resection with curative intent is recommended for intrahepatic CCA, S-1 is an alternative option.
(2) Liver transplantation is a potentially curative option for intrahepatic and perihilar CCA.
(3) FOLFOX (folinic acid, fluorouracil and oxaliplatin) can be recommended as second- line standard of care chemotherapy.
(4) Durvalumab plus Gemcitabine and Cisplatin significantly improved overall survival (OS) versus Gemcitabine plus Cisplatin for advanced biliary tract cancer.
(5) Cirrhosis is one of the risk factors of intrahepatic CCA.
(A) (2)＋(4)
(B) (1)＋(2)＋(3)＋(4)
(C) (2)＋(3)＋(4)
(D) (1)＋(2)＋(3)＋(4)＋(5)
(E) (1)＋(2)＋(4)
